UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

2022-RA-1402-ESGO Implementing HRD testing in routine clinical practice among patients with primary high-grade advanced ovarian cancer

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A333-A333

2022

Volltextzugriff (PDF)

MRI‐based predictive factors of axillary lymph node status in breast cancer

The breast journal, 2020-11, Vol.26 (11), p.2177-2182

2020

Volltextzugriff (PDF)

Reply to: Modified cesarean hysterectomy technique for management of cases of placenta increta and percreta at a tertiary referral hospital in Egypt

Archives of gynecology and obstetrics, 2020-12, Vol.302 (6), p.1545-1546

2020

Volltextzugriff (PDF)

HSP27 modulates tumoural immune evasion by enhancing STAT3-mediated upregulation of PD-L1 and NLRC5 in ovarian cancer

Ecancermedicalscience, 2023, Vol.17, p.1526-1526

2023

Volltextzugriff (PDF)

The use of hysteroscopic endometrectomy in the conservative treatment of early endometrial cancer and atypical hyperplasia in fertile women

Archives of gynecology and obstetrics, 2021-11, Vol.304 (5), p.1299-1305

2021

Volltextzugriff (PDF)

Re-treatment with PARPi in patients with recurrent epithelial ovarian cancer: A single institutional experience

Gynecologic oncology reports, 2022-04, Vol.40, p.100939, Article 100939

2022

Volltextzugriff (PDF)

"You only live twice": multidisciplinary management of catastrophic case in placenta Accreta Spectrum-a case report

BMC pregnancy and childbirth, 2020-02, Vol.20 (1), p.135-135, Article 135

2020

Volltextzugriff (PDF)

Clinical research ethics review process in Lebanon: efficiency and functions of research ethics committees - results from a descriptive questionnaire-based study

Trials, 2018-01, Vol.19 (1), p.27-27, Article 27

2018

Volltextzugriff (PDF)

Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles

Cancer cell international, 2018-01, Vol.18 (1), p.14-14, Article 14

2018

Volltextzugriff (PDF)

B-Cell Lymphoblastic Lymphoma in Relapse Presenting as a Uterine Mass: A Case Report and Review of Literature

Case reports in oncology, 2021-06, Vol.14 (2), p.868-873

2021

Volltextzugriff (PDF)

Maligne mesenchymale Uterustumoren

Frauenheilkunde up2date, 2022-12, Vol.16 (6), p.517-533

2022

Volltextzugriff (PDF)

Genetic profile of borderline ovarian tumors in the Lebanese population by whole‐exome sequencing

International journal of gynecology and obstetrics, 2023-09, Vol.162 (3), p.1027-1032

2023

Volltextzugriff (PDF)

Long term follow-up after minimally invasive sacrocolpopexy

International Urogynecology Journal, 2023-06, Vol.34 (6), p.1279-1283

2023

Volltextzugriff (PDF)

Multidisciplinary management of placenta accreta spectrum in Lebanon: a model for improving outcomes

International journal of gynecological cancer, 2024-10, p.ijgc-2024-006106

2024

Volltextzugriff (PDF)

2022-RA-781-ESGO MLH1 promoter hypermethylation in mismatch repair deficient endometrial cancer. Defining a new subgroup?

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A109-A109

2022

Volltextzugriff (PDF)

Role of fertility-sparing surgery and further prognostic factors in borderline tumors of the ovary

International journal of gynecological cancer, 2024-04, Vol.34 (6), p.898-905

2024

Volltextzugriff (PDF)

PARP inhibitors (PARPi) prolongation after local therapy for oligo-metastatic progression in relapsed ovarian cancer patients

Gynecologic oncology, 2023-06, Vol.173, p.98-105

2023

Volltextzugriff (PDF)

EP225/#828 Difference in hemodynamic parameters in patients (PTS) with advanced epithelial ovarian cancer (EOC) undergoing primary (PDS) or interval debulking surgery (IDS)

International journal of gynecological cancer, 2023-11, Vol.33 (Suppl 4), p.A170-A171

2023

Volltextzugriff (PDF)

450 Surgical management of malignant intestinal obstruction in patients with ovarian cancer – ten-year experience of a tertiary gynecologic oncology department

International journal of gynecological cancer, 2023-09, Vol.33 (Suppl 3), p.A281-A281

2023

Volltextzugriff (PDF)

The Lebanese percreta group: A retrospective cohort study of both radical and conservative management outcomes of abnormally invasive placenta

International journal of gynecology and obstetrics, 2024-11, Vol.167 (2), p.675-684

2024

Volltextzugriff (PDF)

Abstract 2413: TP53 gene mutations differently regulate ovarian cancer metabolism: Ex vivo and in vitro studies

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2413-2413

2018

Volltextzugriff (PDF)

Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status

Gynecologic oncology, 2024-08, Vol.187, p.170-177

2024

Volltextzugriff (PDF)

2022-RA-755-ESGO Comparison of PD-L1 status between primary and paired recurrent/metastatic cervical cancer

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A25-A25

2022

Volltextzugriff (PDF)

2022-RA-778-ESGO Rare gynecological cancers in a gynecologic cancer center: 11-year experience of KEM

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A189-A190

2022

Volltextzugriff (PDF)

Telomere length and its implication as prognostic marker in ovarian cancer patients

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e17055-e17055

2019

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(45)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

2022-RA-1402-ESGO Implementing HRD testing in routine clinical practice among patients with primary high-grade advanced ovarian cancer

MRI‐based predictive factors of axillary lymph node status in breast cancer

Reply to: Modified cesarean hysterectomy technique for management of cases of placenta increta and percreta at a tertiary referral hospital in Egypt

HSP27 modulates tumoural immune evasion by enhancing STAT3-mediated upregulation of PD-L1 and NLRC5 in ovarian cancer

The use of hysteroscopic endometrectomy in the conservative treatment of early endometrial cancer and atypical hyperplasia in fertile women

Re-treatment with PARPi in patients with recurrent epithelial ovarian cancer: A single institutional experience

"You only live twice": multidisciplinary management of catastrophic case in placenta Accreta Spectrum-a case report

Clinical research ethics review process in Lebanon: efficiency and functions of research ethics committees - results from a descriptive questionnaire-based study

Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles

B-Cell Lymphoblastic Lymphoma in Relapse Presenting as a Uterine Mass: A Case Report and Review of Literature

Maligne mesenchymale Uterustumoren

Genetic profile of borderline ovarian tumors in the Lebanese population by whole‐exome sequencing

Long term follow-up after minimally invasive sacrocolpopexy

Multidisciplinary management of placenta accreta spectrum in Lebanon: a model for improving outcomes

2022-RA-781-ESGO MLH1 promoter hypermethylation in mismatch repair deficient endometrial cancer. Defining a new subgroup?

Role of fertility-sparing surgery and further prognostic factors in borderline tumors of the ovary

PARP inhibitors (PARPi) prolongation after local therapy for oligo-metastatic progression in relapsed ovarian cancer patients

EP225/#828 Difference in hemodynamic parameters in patients (PTS) with advanced epithelial ovarian cancer (EOC) undergoing primary (PDS) or interval debulking surgery (IDS)

450 Surgical management of malignant intestinal obstruction in patients with ovarian cancer – ten-year experience of a tertiary gynecologic oncology department

The Lebanese percreta group: A retrospective cohort study of both radical and conservative management outcomes of abnormally invasive placenta

Abstract 2413: TP53 gene mutations differently regulate ovarian cancer metabolism: Ex vivo and in vitro studies

Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status

2022-RA-755-ESGO Comparison of PD-L1 status between primary and paired recurrent/metastatic cervical cancer

2022-RA-778-ESGO Rare gynecological cancers in a gynecologic cancer center: 11-year experience of KEM

Telomere length and its implication as prognostic marker in ovarian cancer patients

Suchergebnisse filtern